Birgitta Sander | Karolinska Institutet

About me
Publications
Grants
CV
Public outreach and news

About me

Birgitta Sander is a Professor of Pathology at the Department of Laboratory Medicine since 2011. Her research is mainly about Mantle cell lymphoma (MCL), which is a form of aggressive cancer that affects the lymphatic system.

Articles

Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2025;26(5):2209
Targeting Tumor Microenvironment Interactions in Chronic Lymphocytic Leukemia Using Leukotriene Inhibitors
Sadeghi L; Merrien M; Bjorkholm M; Osterborg A; Sander B; Claesson H-E; Wright APH
Article: BLOOD. 2024;144(11):1221-1229
Molecular and clinical presentation of UBA1-mutated myelodysplastic syndromes
Sirenko M; Bernard E; Creignou M; Domenico D; Farina A; Ossa JEA; Kosmider O; Hasserjian R; Jadersten M; Germing U; Sanz G; van de Loosdrecht AA; Gurnari C; Follo MY; Thol F; Zamora L; Pinheiro RF; Pellagatti A; Elias HK; Haase D; Sander B; Orna E; Zoldan K; Eder LN; Sperr WR; Thalhammer R; Ganster C; Ades L; Tobiasson M; Palomo L; Della Porta MG; Huberman K; Fenaux P; Belickova M; Savona MR; Klimek VM; Santos FPS; Boultwood J; Kotsianidis I; Santini V; Sole F; Platzbecker U; Heuser M; Valent P; Finelli C; Voso MT; Shih L-Y; Ogawa S; Fontenay M; Jansen JH; Cervera J; Ebert BL; Bejar R; Greenberg PL; Gattermann N; Malcovati L; Cazzola M; Beck DB; Hellstrom-Lindberg E; Papaemmanuil E
Article: CANNABIS AND CANNABINOID RESEARCH. 2024;9(3):e839-e846
Δ⁹-THC and CBD in Plasma, Oral Fluid, Exhaled Breath, and Urine from 23 Patients Administered Sativex
Melen CM; Merrien M; Wasik AM; Sander B; Wahlin BE; Panagiotis G; Beck O
Article: BLOOD. 2024;143(19):1953-1964
SOX11 is a novel binding partner and endogenous inhibitor of SAMHD1 ara-CTPase activity in mantle cell lymphoma
Morsy MHA; Lilienthal I; Lord M; Merrien M; Wasik AM; Sureda-Gomez M; Amador V; Johansson HJ; Lehtio J; Garcia-Torre B; Martin-Subero JI; Tsesmetzis N; Tao S; Schinazi RF; Kim B; Sorteberg AL; Wickstrom M; Sheppard D; Rassidakis GZ; Taylor IA; Christensson B; Campo E; Herold N; Sander B
Article: LEUKEMIA & LYMPHOMA. 2024;65(4):534-537
Outcomes for patients with secondary CNS involvement in relapsed/refractory diffuse large B-cell lymphoma and estimation of eligibility for CAR T-cell therapy
Harrysson S; Eloranta S; Ekberg S; Enblad G; Andersson P-O; Sonnevi K; Ljungqvist M; Sander B; Jerkeman M; Smedby KE
Article: LEUKEMIA. 2024;38(2):610-620
Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosis
Ren W; Wan H; Abd Own S; Berglund M; Wang X; Yang M; Li X; Liu D; Ye X; Sonnevi K; Enblad G; Amini R-M; Sander B; Wu K; Zhang H; Wahlin BE; Smedby KE; Pan-Hammarstrom Q
Article: LEUKEMIA & LYMPHOMA. 2023;64(12):1927-1937
Gene expression and copy number profiling of follicular lymphoma biopsies from patients treated with first-line rituximab without chemotherapy
Leich E; Brodtkorb M; Schmidt T; Altenbuchinger M; Lingjaerde OC; Lockmer S; Holte H; Nedeva T; Grieb T; Sander B; Sundstroem C; Spang R; Kimby E; Rosenwald A
Article: CLINICAL CANCER RESEARCH. 2023;29(20):4256-4267
Integrated Genomic and Transcriptomic Analysis Improves Disease Classification and Risk Stratification of MDS with Ring Sideroblasts
Todisco G; Creignou M; Bernard E; Bjorklund A-C; Moura PL; Tesi B; Mortera-Blanco T; Sander B; Jansson M; Walldin G; Barbosa I; Reinsbach SE; Hofman IJ; Nilsson C; Yoshizato T; Dimitriou M; Chang D; Olafsdottir S; Larsson SV; Tobiasson M; Malcovati L; Woll P; Jacobsen SEW; Papaemmanuil E; Hellstroem-Lindberg E
Journal article: HEMASPHERE. 2023;7(Suppl):e5045724
PB1920: TARGETING THE TUMOR MICROENVIRONMENT INTERACTIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA USING LEUKOTRIENE INHIBITORS
Sadeghi L; Merrien M; Bjorkholm M; Sander B; Claesson H; Wright A
Article: ISCIENCE. 2023;26(6):106864
ADAR1-mediated RNA editing promotes B cell lymphomagenesis
Pecori R; Ren W; Pirmoradian M; Binder M; Papavasiliou N; Wang X; Liu D; Berglund M; Li W; Tasakis RN; Di Giorgio S; Ye X; Li X; Wu K; Helm D; Arnold A; Wust S; Schneider M; Selvasaravanan K-D; Fuell Y; Stafforst T; Amini R-M; Sonnevi K; Enblad G; Sander B; Wahlin BE; Zhang H; Papavasiliou FN; Pan-Hammarstrom Q
Article: HISTOPATHOLOGY. 2023;82(7):1105-1111
Lack of reproducibility of histopathological features in MYC-rearranged large B cell lymphoma using digital whole slide images: a study from the Lunenburg lymphoma biomarker consortium
Natkunam Y; de Jong D; Farinha P; Gaulard P; Klapper W; Rosenwald A; Sander B; Tooze R; Advani R; Burton C; Gribben JG; Kersten M-J; Kimby E; Lenz G; Molina T; Morschhauser F; Scott D; Sehn L; Stevens W; Clear A; Baia M; Habi A; Elsensohn M-H; Langlois-Jacques C; Maucort-Boulch D; Calaminici M
Journal article: HEMATOLOGICAL ONCOLOGY. 2023;41 Suppl 2:302-303
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023.
Ren W; Own SA; Wan H; Berglund M; Wang X; Yang M; Li X; Liu D; Sonnevi K; Enblad G; Amini R; Sander B; Wu K; Zhang H; Wahlin BE; Smedby KE; Pan-Hammarström Q
Article: CANCERS. 2023;15(5):1585
2-Arachidonoylglycerol Modulates CXCL12-Mediated Chemotaxis in Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia
Merrien M; Wasik AM; Melen CM; Morsy MHA; Sonnevi K; Junlen H-R; Christensson B; Wahlin BE; Sander B
Article: FRONTIERS IN ONCOLOGY. 2023;13:1176698
Whole-genome informed circulating tumor DNA analysis by multiplex digital PCR for disease monitoring in B-cell lymphomas: a proof-of-concept study
Haider Z; Wasterlid T; Spangberg LD; Rabbani L; Jylha C; Thorvaldsdottir B; Skaftason A; Awier HN; Krstic A; Gellerbring A; Lyander A; Hagglund M; Jeggari A; Rassidakis G; Sonnevi K; Sander B; Rosenquist R; Tham E; Smedby KE
Article: PHARMACEUTICS. 2022;14(10):2238
A ROR1 Small Molecule Inhibitor (KAN0441571C) Induced Significant Apoptosis of Mantle Cell Lymphoma (MCL) Cells
Ghaderi A; Zhong W; Okhovat MA; Aschan J; Svensson A; Sander B; Schultz J; Olin T; Osterborg A; Hojjat-Farsangi M; Mellstedt H
Article: BLOOD ADVANCES. 2022;6(18):5482-5493
Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV
Los-deVries GT; Stevens WBC; van Dijk E; Langois-Jacques C; Clear AJ; Stathi P; Roemer MGM; Mendeville M; Hijmering NJ; Sander B; Rosenwald A; Calaminici M; Hoster E; Hiddemann W; Gaulard P; Salles G; Horn H; Klapper W; Xerri L; Burton C; Tooze RM; Smith AG; Buske C; Scott DW; Natkunam Y; Advani R; Sehn LH; Raemaekers J; Gribben J; Kimby E; Kersten MJ; Maucort-Boulch D; Ylstra B; de Jong D
Article: BLOOD ADVANCES. 2022;6(18):5403-5414
Genomic characterization of lymphomas in patients with inborn errors of immunity
Ye X; Maglione PJ; Wehr C; Li X; Wang Y; Abolhassani H; Deripapa E; Liu D; Borte S; Du L; Wan H; Ploetner A; Giannoula Y; Ko H-B; Hou Y; Zhu S; Grossman JK; Sander B; Grimbacher B; Hammarstrom L; Fedorova A; Rosenzweig SD; Shcherbina A; Wu K; Warnatz K; Cunningham-Rundles C; Pan-Hammarstrom Q
Article: BLOOD. 2022;140(11):1229-1253
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
Campo E; Jaffe ES; Cook JR; Quintanilla-Martinez L; Swerdlow SH; Anderson KC; Brousset P; Cerroni L; de Leval L; Dirnhofer S; Dogan A; Feldman AL; Fend F; Friedberg JW; Gaulard P; Ghia P; Horwitz SM; King RL; Salles G; San-Miguel J; Seymour JF; Treon SP; Vose JM; Zucca E; Advani R; Ansell S; Au W-Y; Barrionuevo C; Bergsagel L; Chan WC; Cohen JI; d'Amore F; Davies A; Falini B; Ghobrial IM; Goodlad JR; Gribben JG; Hsi ED; Kahl BS; Kim W-S; Kumar S; LaCasce AS; Laurent C; Lenz G; Leonard JP; Link MP; Lopez-Guillermo A; Mateos MV; Macintyre E; Melnick AM; Morschhauser F; Nakamura S; Narbaitz M; Pavlovsky A; Pileri SA; Piris M; Pro B; Rajkumar V; Rosen ST; Sander B; Sehn L; Shipp MA; Smith SM; Staudt LM; Thieblemont C; Tousseyn T; Wilson WH; Yoshino T; Zinzani P-L; Dreyling M; Scott DW; Winter JN; Zelenetz A
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2022;198(2):267-277
Outcomes of relapsed/refractory diffuse large B-cell lymphoma and influence of chimaeric antigen receptor T trial eligibility criteria in second line-A population-based study of 736 patients
Harrysson S; Eloranta S; Ekberg S; Enblad G; El-Galaly TC; Sander B; Sonnevi K; Andersson P-O; Jerkeman M; Smedby KE
Article: LEUKEMIA & LYMPHOMA. 2022;63(6):1387-1397
Clinical effects of a single dose of cannabinoids to patients with chronic lymphocytic leukemia
Melen CM; Merrien M; Wasik AM; Panagiotidis G; Beck O; Sonnevi K; Junlen H-R; Christensson B; Sander B; Wahlin BE
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2022;196(6):1362-1368
Clinical characteristic and outcome of lymphoplasmacytic lymphoma of non-Waldenstrom macroglobulinemia type: A Swedish lymphoma registry study
Brandefors L; Sander B; Lundqvist K; Kimby E
Article: VIRCHOWS ARCHIV. 2022;480(3):655-666
Clinical and biological impact of SAMHD1 expression in mantle cell lymphoma
Merrien M; Wasik AM; Ljung E; Morsy MHA; Rodrigues JDM; Carlsten M; Rassidakis GZ; Christensson B; Kolstad A; Jerkeman M; Ek S; Herold N; Wahlin BE; Sander B
Article: CANCERS. 2022;14(5):1186
Sting Is Commonly and Differentially Expressed in T- and Nk-Cell but Not B-Cell Non-Hodgkin Lymphomas
Xagoraris I; Farrajota Neves da Silva P; Kokaraki G; Stathopoulou K; Wahlin B; Osterborg A; Herold N; Ng S-B; Medeiros LJ; Drakos E; Sander B; Rassidakis GZ
Article: PROSTAGLANDINS & OTHER LIPID MEDIATORS. 2021;156:106575
Intrinsic 5-lipoxygenase activity regulates migration and adherence of mantle cell lymphoma cells
Xia C; Sadeghi L; Straat K; Merrien M; Wright AP; Sander B; Xu D; Osterborg A; Bjorkholm M; Claesson H-E
Article: MEDICAL ONCOLOGY. 2021;38(6):70
The role of BAFF and G-CSF for rituximab-induced late-onset neutropenia (LON) in lymphomas
Tesfa D; Sander B; Lindkvist H; Nilsson C; Kimby E; Hagglund H; Wahlin BE; Klimkowska M; Palmblad J
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2021;106(2):290-293
Graft-versus-mastocytosis effect after donor lymphocyte infusion: Proof of principle
Hagglund H; Yavuz AS; Dreimane A; Malm C; Sundin A; Sander B; Nilsson G
Article: EJHAEM. 2020;1(1):199-207
Marginal zone lymphoma expression of histidine-rich glycoprotein correlates with improved survival
Skare TP; Sjoberg E; Berglund M; Smith RO; Roche FP; Lindskog C; Sander B; Glimelius I; Gholiha AR; Enblad G; Amini R-M; Claesson-Welsh L
Article: CANCERS. 2020;12(5):E1143-1143
Differential B-Cell Receptor Signaling Requirement for Adhesion of Mantle Cell Lymphoma Cells to Stromal Cells
Sadeghi L; Arvidsson G; Merrien M; Wasik AM; Gorgens A; Smith CIE; Sander B; Wright AP
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2020;189(4):707-717
Prognostic implications of the microenvironment for follicular lymphoma under immunomodulation therapy
Menter T; Tzankov A; Zucca E; Kimby E; Hultdin M; Sundstrom C; Beiske K; Cogliatti S; Banz Y; Cathomas G; Katjalainen-Lindsberg M-L; Grobholz R; Mazzucchelli L; Sander B; Hawle H; Hayoz S; Dirnhofer S
Article: LEUKEMIA. 2020;34(1):271-282
A three-dimensional in vitro model of erythropoiesis recapitulates erythroid failure in myelodysplastic syndromes
Elvarsdottir EM; Mortera-Blanco T; Dimitriou M; Bouderlique T; Jansson M; Hofman IJF; Conte S; Karimi M; Sander B; Douagi I; Woll PS; Hellstrom-Lindberg E
Article: JOURNAL OF CLINICAL ONCOLOGY. 2019;37(35):3359-3368
Prognostic Significance of MYC Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker Consortium
Rosenwald A; Bens S; Advani R; Barrans S; Copie-Bergman C; Elsensohn M-H; Natkunam Y; Calaminici M; Sander B; Baia M; Smith A; Painter D; Pham L; Zhao S; Ziepert M; Jordanova ES; Molina TJ; Kersten MJ; Kimby E; Klapper W; Raemaekers J; Schmitz N; Jardin F; Stevens WBC; Hoster E; Hagenbeek A; Gribben JG; Siebert R; Gascoyne RD; Scott DW; Gaulard P; Salles G; Burton C; de Jong D; Sehn LH; Maucort-Boulch D
Journal article: HEMATOLOGICAL ONCOLOGY. 2019;37(S2):572
THE CANNABINOID STUDY – 01: INVESTIGATING THE EFFECTS OF CANNABINOIDS IN INDOLENT LEUKEMIC B‐CELL LYMPHOMA
Melén CM; Merrien M; Wasik AM; Sonnevi K; Junlén H; Christensson B; Sander B; Wahlin BE
Article: PEDIATRIC TRANSPLANTATION. 2019;23(4):e13408
Strong expression of p53 protein in bone marrow samples after hematopoietic stem cell transplantation indicates risk of relapse in pediatric acute lymphoblastic leukemia patients
Mattsson K; Honkaniemi E; Ramme K; Barbany G; Sander BM; Gustafsson BM
Journal article: HEMASPHERE. 2019;3(S1):490-491
PS1082 PROGNOSTIC SIGNIFICANCE OF SAMHD1 EXPRESSION IN DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL)
Xagoraris I; Herold N; Sander B; Smedby KE; Rassidakis G
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2019;185(4):708-712
Expression of GNAZ, encoding the Gα_z protein, predicts survival in mantle cell lymphoma
Mundt F; Merrien M; Nygren L; Sutton LA; Christensson B; Wahlin BE; Rosenquist R; Sander B; Wasik AM
Journal article: BLOOD. 2018;132(Supplement 1):4136
SAMHD1 Is Variably Expressed in Mantle Cell Lymphoma and Correlated to SOX11 but Not to Survival
Wasik AM; Marin E; Merrien M; de Matos Rodrigues J; Lord M; Xagoraris I; Christensson B; Rassidakis G; Jerkeman M; Ek S; Sander B
Article: SCIENTIFIC REPORTS. 2018;8(1):15841
Single-Stranded Nucleic Acids Regulate TLR3/4/7 Activation through Interference with Clathrin-Mediated Endocytosis
Jarver P; Dondalska A; Poux C; Sandberg A; Bergenstrahle J; Skold AE; Dereuddre-Bosquet N; Martinon F; Palsson S; Zaghloul E; Brodin D; Sander B; Lennox KA; Behlke MA; EL-Andaloussi S; Lehtio J; Lundeberg J; LeGrand R; Spetz A-L
Article: HAEMATOLOGICA. 2018;103(4):666-678
Mixed-species RNAseq analysis of human lymphoma cells adhering to mouse stromal cells identifies a core gene set that is also differentially expressed in the lymph node microenvironment of mantle cell lymphoma and chronic lymphocytic leukemia patients
Arvidsson G; Henriksson J; Sander B; Wright AP
Article: BLOOD ADVANCES. 2018;2(6):621-625
Clinical and functional impact of recurrent S1PR1 mutations in mantle cell lymphoma
Wasik AM; Wu C; Mansouri L; Rosenquist R; Pan-Hammarstrom Q; Sander B
Journal article: BLOOD. 2017;130(Suppl_1):822
The Impact of Upfront Autologous Transplant on the Survival of Adult Patients with ALCL and PTCL-NOS According to Their ALK, DUSP22 and TP63 Gene Rearrangement Status - a Joined Nordic Lymphoma Group and Mayo Clinic Analysis
Pedersen MB; Relander T; Lauritzsen GF; Ellin F; Leppä S; Mannisto S; Jantunen E; Ketterling RP; Bedroske P; Luoma I; Sattler C; Delabie JMA; Sundstrom C; Sander B; Karjalainen-Lindsberg M-L; Hamilton-Dutoit S; Ehinger M; Vornanen M; Ralfkiaer E; Boddicker R; Bennani NN; Oishi N; Moeller MB; Noergaard P; Cerhan JR; Maurer MJ; Liestol K; Toldbod H; Feldman AL; d'Amore F
Article: HAEMATOLOGICA. 2017;102(8):1413-1423
Prognostic relevance of CD163 and CD8 combined with EZH2 and gain of chromosome 18 in follicular lymphoma: a study by the Lunenburg Lymphoma Biomarker Consortium
Stevens WBC; Mendeville M; Redd R; Clear AJ; Bladergroen R; Calaminici M; Rosenwald A; Hoster E; Hiddemann W; Gaulard P; Xerri L; Salles G; Klapper W; Pfreundschuh M; Jack A; Gascoyne RD; Natkunam Y; Advani R; Kimby E; Sander B; Sehn LH; Hagenbeek A; Raemaekers J; Gribben J; Kersten MJ; Ylstra B; Weller E; de Jong D
Article: AMERICAN JOURNAL OF PATHOLOGY. 2017;187(7):1454-1458
Numerous Ontogenetic Roads to Mantle Cell Lymphoma Immunogenetic and Immunohistochemical Evidence
Pouliou E; Xochelli A; Kanellis G; Stalika E; Sutton L-A; Navarro A; Agathangelidis A; Dimosthenous K; Anagnostopoulos A; Patsouris E; Korkolopoulou P; Sundstrom C; Ghia P; Ponzoni M; Sander B; Campo E; Rosenquist R; Hadzidimitriou A; Stamatopoulos K; Papadaki T
Journal article: BLOOD. 2016;128(22):5338
Immune Cell Dynamics in Nordic FL Patients in the SAKK 35/10 Randomized Trial with Rituximab and Lenalidomide
Lockmer S; Wahlin BE; Ostenstad B; Jeppson-Ahlberg Å; Sander B; Kimby E
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2016;175(1):102-114
The tumour microenvironment influences survival and time to transformation in follicular lymphoma in the rituximab era
Blaker YN; Spetalen S; Brodtkorb M; Lingjaerde OC; Beiske K; Ostenstad B; Sander B; Wahlin BE; Melen CM; Myklebust JH; Holte H; Delabie J; Smeland EB
Journal article: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 2016;16:s111-s112
Immune Cell Modulations in Nordic FL Patients After Lenalidomide in the SAKK 35/10 Trial
Lockmer S; Jeppsson-Ahlberg Å; Sander B; Kimby E; Wahlin B
Article: ONCOTARGET. 2016;7(25):38180-38190
Genetic heterogeneity in primary and relapsed mantle cell lymphomas: Impact of recurrent CARD11 mutations
Wu C; de Miranda NFCC; Chen L; Wasik AM; Mansouri L; Jurczak W; Galazka K; Dlugosz-Danecka M; Machaczka M; Zhang H; Peng R; Morin RD; Rosenquist R; Sander B; Pan-Hammarstrom Q
Article: ACTA DERMATO-VENEREOLOGICA. 2016;96(5):602-612
Multidisciplinary Management of Mastocytosis: Nordic Expert Group Consensus
Broesby-Olsen S; Dybedal I; Gulen T; Kristensen TK; Moller MB; Ackermann L; Saaf M; Karlsson M; Agertoft L; Brixen K; Hermann P; Stylianou E; Mortz CG; Torfing T; Havelund T; Sander B; Bergstrom A; Bendix M; Garvey LH; Weis Bjerrum O; Valent P; Bindslev-Jensen C; Nilsson G; Vestergaard H; Hagglund H
Article: EPIGENETICS. 2016;11(5):335-343
Epigenetic silencing of miR-26A1 in chronic lymphocytic leukemia and mantle cell lymphoma: Impact on EZH2 expression
Kopparapu PK; Bhoi S; Mansouri L; Arabanian LS; Plevova K; Pospisilova S; Wasik AM; Croci GA; Sander B; Paulli M; Rosenquist R; Kanduri M
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2015;171(4):478-490
Aberrant splicing of genes involved in haemoglobin synthesis and impaired terminal erythroid maturation in SF3B1 mutated refractory anaemia with ring sideroblasts
Conte S; Katayama S; Vesterlund L; Karimi M; Dimitriou M; Jansson M; Mortera-Blanco T; Unneberg P; Papaemmanuil E; Sander B; Skoog T; Campbell P; Walfridsson J; Kere J; Hellstrom-Lindberg E
Article: PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS. 2015;100:33-40
Phosphorylation of serine 523 on 5-lipoxygenase in human B lymphocytes
Mahshid Y; Markoutsa S; Dincbas-Renqvist V; Sueruen D; Christensson B; Sander B; Bjorkholm M; Sorg BL; Radmark O; Claesson H-E
Article: JOURNAL OF EXPERIMENTAL MEDICINE. 2015;212(6):833-843
Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia
Mansouri L; Sutton L-A; Ljungstrom V; Bondza S; Arngarden L; Bhoi S; Larsson J; Cortese D; Kalushkova A; Plevova K; Young E; Gunnarsson R; Falk-Sorqvist E; Lonn P; Muggen AF; Yan X-J; Sander B; Enblad G; Smedby KE; Juliusson G; Belessi C; Rung J; Chiorazzi N; Strefford JC; Langerak AW; Pospisilova S; Davi F; Hellstrom M; Jernberg-Wiklund H; Ghia P; Soderberg O; Stamatopoulos K; Nilsson M; Rosenquist R
Article: LEUKEMIA & LYMPHOMA. 2015;56(5):1425-1431
Flow cytometric analysis of SOX11: a new diagnostic method for distinguishing B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma from mantle cell lymphoma
Wasik AM; Priebe V; Lord M; Jeppsson-Ahlberg A; Christensson B; Sander B
Article: ONCOGENE. 2015;34(10):1231-1240
High-resolution chromatin immunoprecipitation (ChIP) sequencing reveals novel binding targets and prognostic role for SOX11 in mantle cell lymphoma
Kuo P-Y; Leshchenko VV; Fazzari MJ; Perumal D; Gellen T; He T; Iqbal J; Baumgartner-Wennerholm S; Nygren L; Zhang F; Zhang W; Suh KS; Goy A; Yang DT; Chan W-C; Kahl BS; Verma AK; Gascoyne RD; Kimby E; Sander B; Ye BH; Melnick AM; Parekh S
Article: PEERJ. 2015;3:e1056
Influence of rimonabant treatment on peripheral blood mononuclear cells; flow cytometry analysis and gene expression profiling
Almestrand S; Wang X; Jeppsson-Ahlberg A; Nordgren M; Flygare J; Christensson B; Rossner S; Sander B
Article: CLINICAL CANCER RESEARCH. 2014;20(23):6096-6104
T-Cell Levels Are Prognostic in Mantle Cell Lymphoma
Nygren L; Wasik AM; Baumgartner-Wennerholm S; Jeppsson-Ahlberg A; Klimkowska M; Andersson P; Buhrkuhl D; Christensson B; Kimby E; Wahlin BE; Sander B
Article: ONCOSCIENCE. 2014;1(8):550-557
Perturbations of the endocannabinoid system in mantle cell lymphoma: correlations to clinical and pathological features.
Wasik AM; Nygren L; Almestrand S; Zong F; Flygare J; Wennerholm SB; Saft L; Andersson P; Kimby E; Wahlin BE; Christensson B; Sander B
Article: ACTA DERMATO-VENEREOLOGICA. 2014;94(5):583-584
Increased Risk of Malignant Melanoma in Patients with Systemic Mastocytosis?
Hagglund H; Sander B; Gulen T; Lindelof B; Nilsson G
Article: CLINICAL AND EXPERIMENTAL ALLERGY. 2014;44(9):1179-1187
The presence of mast cell clonality in patients with unexplained anaphylaxis
Gulen T; Hagglund H; Sander B; Dahlen B; Nilsson G
Article: MEDICAL ONCOLOGY. 2014;31(8):123
Analysis of V600E BRAF and D816V KIT mutations in systemic mastocytosis
Hagglund H; Sander B; Ahmadi A; Gulen T; Nilsson G
Article: PEDIATRIC HEMATOLOGY AND ONCOLOGY. 2014;31(4):327-339
Elevated p53 Protein Expression; A Predictor of Relapse in Rare Chronic Myeloid Malignancies in Children?
Honkaniemi E; Mattsson K; Barbany G; Sander B; Gustafsson B
Article: HAEMATOLOGICA. 2014;99(4):715-725
The reliability of immunohistochemical analysis of the tumor microenvironment in follicular lymphoma: a validation study from the Lunenburg Lymphoma Biomarker Consortium
Sander B; de Jong D; Rosenwald A; Xie W; Balague O; Calaminici M; Carreras J; Gaulard P; Gribben J; Hagenbeek A; Kersten MJ; Molina TJ; Lee A; Montes-Moreno S; Ott G; Raemaekers J; Salles G; Sehn L; Thorns C; Wahlin BE; Gascoyne RD; Weller E
Article: BLOOD. 2014;123(13):2054-2061
Inhibition of lymphoma vascularization and dissemination by estrogen receptor β agonists
Yakimchuk K; Hasni MS; Guan J; Chao MP; Sander B; Okret S
Article: LEUKEMIA & LYMPHOMA. 2014;55(2):288-295
Higher World Health Organization grades of follicular lymphoma correlate with better outcome in two Nordic Lymphoma Group trials of rituximab without chemotherapy
Wahlin BE; Sundstrom C; Sander B; Christensson B; Jeppsson-Ahlberg A; Hjalmarsson E; Holte H; Ostenstad B; Brown PD; Smeland EB; Kimby E
Article: EPIGENETICS. 2013;8(12):1280-1288
A key role for EZH2 in epigenetic silencing of HOX genes in mantle cell lymphoma
Kanduri M; Sander B; Ntoufa S; Papakonstantinou N; Sutton L; Stamatopoulos K; Kanduri C; Rosenquist R
Article: CLINICAL AND TRANSLATIONAL ALLERGY. 2013;3(1):22
The significance of diagnosing associated clonal mast cell diseases in patients with venom-induced anaphylaxis and the role of bone marrow investigation.
Gülen T; Dahlén B; Sander B; Hägglund H; Nilsson G
Article: SCIENTIFIC REPORTS. 2013;3:1400
SOXC transcription factors in mantle cell lymphoma: the role of promoter methylation in SOX11 expression
Wasik AM; Lord M; Wang X; Zong F; Andersson P; Kimby E; Christensson B; Karimi M; Sander B
Article: MEDICAL ONCOLOGY. 2012;29(5):3540-3546
Systemic mastocytosis: progressive evolution of an occult disease into fatal mast cell leukemia: unique findings on an unusual hematological neoplasm
Gulen T; Sander B; Nilsson G; Palmblad J; Sotlar K; Horny H-P; Hagglund H
Article: STEM CELLS AND DEVELOPMENT. 2012;21(17):3147-3151
Treatment of Familial Hemophagocytic Lymphohistiocytosis with Third-Party Mesenchymal Stromal Cells
Mougiakakos D; Machaczka M; Jitschin R; Klimkowska M; Entesarian M; Bryceson YT; Henter J-I; Sander B; Le Blanc K
Article: CANCER RESEARCH. 2012;72(20):5307-5316
Molecular Subsets of Mantle Cell Lymphoma Defined by the IGHV Mutational Status and SOX11 Expression Have Distinct Biologic and Clinical Features
Navarro A; Clot G; Royo C; Jares P; Hadzidimitriou A; Agathangelidis A; Bikos V; Darzentas N; Papadaki T; Salaverria I; Pinyol M; Puig X; Palomero J; Carmela Vegliante M; Amador V; Martinez-Trillos A; Stefancikova L; Wiestner A; Wilson W; Pott C; Jose Calasanz M; Trim N; Erber W; Sander B; Ott G; Rosenwald A; Colomer D; Gine E; Siebert R; Lopez-Guillermo A; Stamatopoulos K; Bea S; Campo E
Article: BLOOD. 2012;119(18):4215-4223
Prognostic role of SOX11 in a population-based cohort of mantle cell lymphoma
Nygren L; Wennerholm SB; Klimkowska M; Christensson B; Kimby E; Sander B
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2012;87(4):361-367
Mantle cell lymphoma displays a homogenous methylation profile: A comparative analysis with chronic lymphocytic leukemia
Halldorsdottir AM; Kanduri M; Marincevic M; Mansouri L; Isaksson A; Goransson H; Axelsson T; Agarwal P; Jernberg-Wiklund H; Stamatopoulos K; Sander B; Ehrencrona H; Rosenquist R
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2012;18(4):557-564
Long-Term Complications, Immunologic Effects, and Role of Passage for Outcome in Mesenchymal Stromal Cell Therapy
von Bahr L; Sundberg B; Lonnies L; Sander B; Karbach H; Hagglund H; Ljungman P; Gustafsson B; Karlsson H; Le Blanc K; Ringden O
Article: PLOS ONE. 2012;7(2):e31366
Inhibition of the Intrinsic but Not the Extrinsic Apoptosis Pathway Accelerates and Drives Myc-Driven Tumorigenesis Towards Acute Myeloid Leukemia
Hoegstrand K; Hejll E; Sander B; Rozell B; Larsson L-G; Grandien A
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2012;156(2):225-233
Clinical significance of the WHO grades of follicular lymphoma in a population-based cohort of 505 patients with long follow-up times
Wahlin BE; Yri OE; Kimby E; Holte H; Delabie J; Smeland EB; Sundstrom C; Christensson B; Sander B
Article: BLOOD CANCER JOURNAL. 2012;2(1):e52
Entourage: the immune microenvironment following follicular lymphoma
Wahlin BE; Sander B; Christensson B; Ostenstad B; Holte H; Brown PD; Sundstrom C; Kimby E
Article: JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY. 2011;33(8):e363-e367
Acute Respiratory Failure in 3 Children With Juvenile Myelomonocytic Leukemia
Gustafsson B; Hellebostad M; Ifversen M; Sander B; Hasle H
Journal article: BLOOD. 2011;118(21):3651
SOX11 Expression Versus Indolent Clinical Course in Mantle Cell Lymphomas in a Population-Based Cohort From the Stockholm Region – SOX11 Negative Tumors Are Mostly p53 Positive, Contributing to Shorter Overall Survival,
Sander B; Klimkowska M; Nygren L; Baumgartner S; Christensson B; Kimby E
Journal article: BLOOD. 2011;118(21):1592
Prognostic Impact of Clinical and Tumor Associated Variables in a Population-Based Cohort of Mantle Cell Lymphomas in the Stockholm Region Between 1998–2010
Wennerholm SB; Klimkowska M; Nygren L; Kimby E; Sander B
Journal article: BLOOD. 2011;118(21):1641
Increasing Grades of Follicular Lymphoma Correlate with Better Prognosis in Patients Treated with Rituximab
Wahlin BE; Sundström C; Holte H; Sander B; Østenstad B; de Nully Brown P; Smeland EB; Delabie J; Christensson B; Kimby E
Article: CELL DEATH & DISEASE. 2011;2(11):e225
WIN55,212-2 induces cytoplasmic vacuolation in apoptosis-resistant MCL cells
Wasik AM; Almestrand S; Wang X; Hultenby K; Dackland A-L; Andersson P; Kimby E; Christensson B; Sander B
Article: ACTA PAEDIATRICA. 2011;100(10):e186-e189
Maintenance of remission with cyclosporine in paediatric patients with Kimura's disease - two case reports
Soeria-Atmadja S; Oskarsson T; Celci G; Sander B; Berg U; Gustafsson B
Journal article: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 2011;11:s238
4.28 FISH on Paraffin-Embedded Tissue Samples is Feasible and of Prognostic Importance in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Norin S; Wallblom A; Sander B; Kimby E
Article: BLOOD. 2011;118(11):3088-3095
Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases
Hadzidimitriou A; Agathangelidis A; Darzentas N; Murray F; Delfau-Larue M-H; Pedersen LB; Navarro Lopez A; Dagklis A; Rombout P; Beldjord K; Kolstad A; Dreyling MH; Anagnostopoulos A; Tsaftaris A; Mavragani-Tsipidou P; Rosenwald A; Ponzoni M; Groenen P; Ghia P; Sander B; Papadaki T; Campo E; Geisler C; Rosenquist R; Davi F; Pott C; Stamatopoulos K
Article: SEMINARS IN DIAGNOSTIC PATHOLOGY. 2011;28(3):245-255
Mantle cell lymphoma: recent insights into pathogenesis, clinical variability, and new diagnostic markers
Sander B
Article: ARTHRITIS & RHEUMATOLOGY. 2011;63(8):2209-2214
Late-Onset Neutropenia Following Rituximab Therapy in Rheumatic Diseases: Association With B Lymphocyte Depletion and Infections
Tesfa D; Ajeganova S; Hagglund H; Sander B; Fadeel B; Hafstrom I; Palmblad J
Article: BLOOD. 2011;117(26):7070-7078
Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: a study from the Lunenburg Lymphoma Biomarker Consortium
Salles G; de Jong D; Xie W; Rosenwald A; Chhanabhai M; Gaulard P; Klapper W; Calaminici M; Sander B; Thorns C; Campo E; Molina T; Lee A; Pfreundschuh M; Horning S; Lister A; Sehn LH; Raemaekers J; Hagenbeek A; Gascoyne RD; Weller E
Article: CLINICAL CANCER RESEARCH. 2011;17(12):4136-4144
T Cells in Tumors and Blood Predict Outcome in Follicular Lymphoma Treated with Rituximab
Wahlin BE; Sundstrom C; Holte H; Hagberg H; Erlanson M; Nilsson-Ehle H; Linden O; Nordstrom M; Ostenstad B; Geisler CH; Brown PDN; Lehtinen T; Maisenholder M; Tierens AM; Sander B; Christensson B; Kimby E
Article: GENES CHROMOSOMES & CANCER. 2011;50(2):113-121
High-Resolution Genomic Screening in Mantle Cell Lymphoma-Specific Changes Correlate with Genomic Complexity, the Proliferation Signature and Survival
Halldorsdottir AM; Sander B; Goransson H; Isaksson A; Kimby E; Mansouri M; Rosenquist R; Ehrencrona H
Article: PLOS ONE. 2010;5(11):e14085
Gene Expression Profiling and Chromatin Immunoprecipitation Identify DBN1, SETMAR and HIG2 as Direct Targets of SOX11 in Mantle Cell Lymphoma
Wang X; Bjoerklund S; Wasik AM; Grandien A; Andersson P; Kimby E; Dahlman-Wright K; Zhao C; Christensson B; Sander B
Journal article: BLOOD. 2010;116(21):536
Genome-Wide Array-Based Methylation Profiling Reveals Preferential Methylation of Homeobox Transcription Factor Genes In Mantle Cell Lymphoma and Pro-Apoptotic Genes In Chronic Lymphocytic Leukemia
Halldorsdottir AM; Kanduri M; Marincevic M; Göransson H; Isaksson A; Mansouri M; Stamatopoulos K; Sander B; Ehrencrona H; Rosenquist R
Journal article: BLOOD. 2010;116(21):4618
Cytogenetic Abnormalities In the Spleen In CLL Patients.
Norin S; Wallblom A; Aggarwal M; Sander B; Kimby E
Article: CLINICAL CANCER RESEARCH. 2010;16(2):637-650
A Unifying Microenvironment Model in Follicular Lymphoma: Outcome Is Predicted by Programmed Death-1-Positive, Regulatory, Cytotoxic, and Helper T Cells and Macrophages
Wahlin BE; Aggarwal M; Montes-Moreno S; Francisco Gonzalez L; Roncador G; Sanchez-Verde L; Christensson B; Sander B; Kimby E
Journal article: BLOOD. 2009;114(22):3953
Several Immune Cell Subsets Are Associated with Outcome in the Microenvironment of Follicular Lymphoma.
Wahlin BE; Aggarwal M; Montes-Moreno S; Gonzalez LF; Roncador G; Sanchez-Verde L; Christensson B; Sander B; Kimby E
Article: JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY. 2009;31(9):696-701
Expression of VEGF and VEGF Receptors in Childhood Precursor B-cell Acute Lymphoblastic Leukemia Evaluated by Immunohistochemistry
Diffner E; Gauffin F; Anagnostaki L; Nordgren A; Gustafsson B; Sander B; Gustafsson B; Persson JL
Article: MOLECULAR CANCER RESEARCH. 2009;7(7):1086-1098
Potentiation of Cannabinoid-Induced Cytotoxicity in Mantle Cell Lymphoma through Modulation of Ceramide Metabolism
Gustafsson K; Sander B; Bielawski J; Hannun YA; Flygare J
Journal article: JOURNAL OF CLINICAL PATHOLOGY. 2009;62(2):128-138
Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium) (Retracted article. See vol. 65, pg. 861, 2012)
de Jong D; Xie W; Rosenwald A; Chhanabhai M; Gaulard P; Klapper W; Lee A; Sander B; Thorns C; Campo E; Molina T; Hagenbeek A; Horning S; Lister A; Raemaekers J; Salles G; Gascoyne RD; Weller E
Article: BMC IMMUNOLOGY. 2009;10:2
High expression of 5-lipoxygenase in normal and malignant mantle zone B lymphocytes
Mahshid Y; Lisy M-R; Wang X; Spanbroek R; Flygare J; Christensson B; Bjorkholm M; Sander B; Habenicht AJR; Claesson H-E
Article: PEDIATRIC HEMATOLOGY AND ONCOLOGY. 2009;26(1):48-56
EXPRESSION OF PTEN AND SHP1, INVESTIGATED FROM TISSUE MICROARRAYS IN PEDIATRIC ACUTE LYMPHOBLASTIC, LEUKEMIA
Gauffin F; Diffner E; Gustafsson B; Nordgren A; Wingren AG; Sander B; Persson JL; Gustafsson B
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2008;143(2):248-252
The subcellular Sox11 distribution pattern identifies subsets of mantle cell lymphoma: correlation to overall survival
Wang X; Asplund AC; Porwit A; Flygare J; Smith CIE; Christensson B; Sander B
Article: INTERNATIONAL JOURNAL OF CANCER. 2008;123(5):1025-1033
Expression of cannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma: Growth inhibition by receptor activation
Gustafsson K; Wang X; Severa D; Eriksson M; Kimby E; Merup M; Christensson B; Flygare J; Sander B
Article: AMERICAN JOURNAL OF CLINICAL PATHOLOGY. 2008;129(4):630-638
A subset of CD5-diffuse large B-cell lymphomas expresses nuclear cyclin D1 with aberrations at the CCND1 locus
Ehinger M; Linderoth J; Christerisson B; Sander B; Cavallin-Stahl E
Article: MEDICAL ONCOLOGY. 2008;25(4):374-379
Late-onset neutropenia associated with rituximab therapy: evidence for a maturation arrest at the (pro)myelocyte stage of granulopoiesis
Tesfa D; Gelius T; Sander B; Kimby E; Fadeel B; Palmblad J; Hagglund H
Journal article: BLOOD. 2007;110(11):2611
Grading Follicular Lymphoma: No Difference between 1, 2 and 3a, but 3b Is Something Else.
Wahlin BE; Sander B; Christensson B; Kimby E
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2007;104(27):11406-11411
Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q-syndrome patients
Pellagatti A; Jaedersten M; Forsblom A-M; Cattan H; Christensson B; Emanuelsson EK; Merup M; Nilsson L; Samuelsson J; Sander B; Wainscoat JS; Boultwood J; Helistroem-Lindberg E
Article: FREE RADICAL BIOLOGY AND MEDICINE. 2007;43(1):90-99
Redox-signaling transmitted in trans to neighboring cells by melanoma-derived TNF-containing exosomes
Soderberg A; Barral AM; Soderstrom M; Sander B; Rosen A
Article: LEUKEMIA & LYMPHOMA. 2007;48(7):1344-1352
Characterization of genetic changes in MCL by interphase FISH on tissue sections
Sander B; Wallblom A; Ekroth A; Porwit A; Kimby E
Article: JOURNAL OF CLINICAL ONCOLOGY. 2007;25(7):805-812
Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: Validation of tissue microarray as a prerequisite for broad clinical applications - A study from the Lunenburg Lymphoma Biomarker Consortium
de Jong D; Rosenwald A; Chhanabhai M; Gaulard P; Klapper W; Lee A; Sander B; Thorns C; Campo E; Molina T; Norton A; Hagenbeek A; Horning S; Lister A; Raemaekers J; Gascoyne RD; Salles G; Weller E
Article: CLINICAL CANCER RESEARCH. 2007;13(2):388-397
CD8+T-cell content in diagnostic lymph nodes measured by flow cytometry is a predictor of survival in follicular lymphoma
Wahlin BE; Sander B; Christensson B; Kimby E
Journal article: BLOOD. 2006;108(11):855
Lenalidomide Up-Regulates SPARC and Inhibits In Vitro Growth of the Malignant Clone in Myelodysplastic Syndrome Patients with 5q Deletion.
Pellagatti A; Jädersten M; Forsblom A-M; Cattan H; Christensson B; Emanuelsson EK; Merup M; Nilsson L; Samuelsson J; Sander B; Wainscoat JS; Boultwood J; Hellström-Lindberg E
Article: MOLECULAR PHARMACOLOGY. 2006;70(5):1612-1620
Cannabinoid receptor-mediated apoptosis induced by R(+)-methanandamide and Win55,212-2 is associated with ceramide accumulation and p38 activation in mantle cell lymphoma
Gustafsson K; Christensson B; Sander B; Flygare J
Article: FEBS LETTERS. 2005;579(30):6885-6889
Cannabinoid receptor ligands mediate growth inhibition and cell death in mantle cell lymphoma
Flygare J; Gustafsson K; Kimby E; Christensson B; Sander B
Article: INTERNATIONAL JOURNAL OF CANCER. 2005;117(3):418-430
Mantle cell lymphomas with low levels of cyclin D1 long mRNA transcripts are highly proliferative and can be discriminated by elevated cyclin A2 and cyclin B1
Sander B; Flygare J; Porwit-MacDonald A; Smith CIE; Emanuelsson E; Kimby E; Liden J; Christensson B
Article: MELANOMA RESEARCH. 2004;14(4):251-255
Germline CDKN2A mutations are rare in child and adolescent cutaneous melanoma
Berg P; Wennberg AM; Tuominen R; Sander B; Rozell BL; Platz A; Hansson J
Article: MEDICAL ONCOLOGY. 2004;21(3):273-284
Posttransplant lymphoma -: A single-center experience of 500 liver transplantations
Norin S; Kimby E; Ericzon BG; Christensson B; Sander B; Söderdahl G; Häggland H
Article: JOURNAL OF NEUROIMMUNOLOGY. 2003;145(1-2):115-126
Phenotypes indicating cytolytic properties of Borrelia-specific interferon-gamma secreting cells in chronic Lyme neuroborreliosis.
Ekerfelt C; Jarefors S; Tynngård N; Hedlund M; Sander B; Bergström S; Forsberg P; Ernerudh J
Article: LEUKEMIA. 2003;17(9):1880-1890
High level of cannabinoid receptor 1, absence of regulator of G protein signalling 13 and differential expression of Cyclin D1 in mantle cell lymphoma
Islam TC; Asplund AC; Lindvall JM; Nygren L; Liden J; Kimby E; Christensson B; Smith CIE; Sander B
Article: BLOOD. 2003;101(10):4047-4054
Mutated V_H genes and preferential V_H3-21 use define new subsets of mantle cell lymphoma
Walsh SH; Thorsélius M; Johnson A; Söderberg O; Jerkernan M; Björck E; Eriksson I; Thunberg U; Landgren O; Ehinger M; Löfvenberg E; Wallman K; Enblad G; Sander B; Porwit-MacDonald A; Dictor M; Olofsson T; Sundström C; Roos G; Rosenquist R
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2002;34(10):759-762
IL-8 and tumor necrosis factor alpha in heart valves from patients with infective endocarditis.
Ekdahl C; Broqvist M; Franzén S; Ljunghusen O; Maller R; Sander B
Article: MELANOMA RESEARCH. 2000;10(4):331-343
Thioredoxin, thioredoxin reductase and tumour necrosis factor-α expression in melanoma cells:: correlation to resistance against cytotoxic attack
Barral AM; Källström R; Sander B; Rosén A
Article: INTERNATIONAL JOURNAL OF CANCER. 1999;80(5):646-651
Cutaneous malignant melanoma in Swedish children and teenagers 1973-1992: a clinico-pathological study of 130 cases.
Sander B; Karlsson P; Rosdahl I; Westermark P; Boeryd B
Article: ACTA DERMATO-VENEREOLOGICA. 1998;78(4):289-292
Increasing incidence of cutaneous malignant melanoma in children and adolescents 12-19 years of age in Sweden 1973-92.
Karlsson P; Boeryd B; Sander B; Westermark P; Rosdahl I
Article: CANCER IMMUNOLOGY IMMUNOTHERAPY. 1997;44(6):335-340
Variable expression of tumor necrosis factor alpha in human malignant melanoma localized by in situ hybridization for mRNA.
Bergenwald C; Westermark G; Sander B
Article: JOURNAL OF AUTOIMMUNITY. 1997;10(4):347-355
Effects of the murine genotype on T cell activation and cytokine production in murine mercury-induced autoimmunity.
Johansson U; Sander B; Hultman P
Article: MELANOMA RESEARCH. 1997;7(2):139-145
Effect of interferon-alpha on the expression of tumour necrosis factor-alpha by metastatic malignant melanoma in vivo.
Håkansson A; Gustafsson B; Krysander L; Bergenwald C; Sander B; Håkansson L
Article: JOURNAL OF UROLOGY. 1996;156(2):536-541
Localization of IL-1, IL-2, IL-4, IL-8 and TNF in superficial bladder tumors treated with intravesical Bacillus Calmette-Guerin
Sander B; Damm O; Gustafsson B; Andersson U; Hakansson L
Article: INTERNATIONAL JOURNAL OF CANCER. 1996;66(1):42-47
Tumor necrosis factor-alpha expression in human primary malignant malanoma and it relationship to tumor infiltration by CD3+ cells.
Sander B; Boeryd B
Article: IMMUNOLOGY. 1995;86(4):512-518
Sequential production of Th1 and Th2 cytokines in response to live Bacillus Calmette-Guerin
Sander B; SkansenSaphir U; Damm O; Hakansson L; Andersson J; Andersson U
Journal article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 1994;39(4):380-386
HIV-1 INHIBITS LEISHMANIA-INDUCED CELL-PROLIFERATION BUT NOT PRODUCTION OF INTERLEUKIN-6 AND TUMOR-NECROSIS-FACTOR-ALPHA
WOLDAY D; AKUFFO H; BRITTON S; HATHAWAY A; SANDER B
Journal article: JOURNAL OF IMMUNOLOGICAL METHODS. 1993;166(2):201-214
SIMILAR FREQUENCIES AND KINETICS OF CYTOKINE PRODUCING CELLS IN MURINE PERIPHERAL-BLOOD AND SPLEEN - CYTOKINE DETECTION BY IMMUNOASSAY AND INTRACELLULAR IMMUNOSTAINING
SANDER B; HOIDEN I; ANDERSSON U; MOLLER E; ABRAMS JS
Journal article: EUROPEAN JOURNAL OF IMMUNOLOGY. 1991;21(8):1887-1892
DIFFERENTIAL REGULATION OF LYMPHOKINE PRODUCTION IN MITOGEN-STIMULATED MURINE SPLEEN-CELLS
SANDER B; CARDELL S; MOLLER G; MOLLER E
Journal article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 1991;33(3):287-296
INTERLEUKIN-4 AND INTERFERON-GAMMA PRODUCTION IN RESTIMULATED CD4+ AND CD8+ CELLS INDICATES MEMORY TYPE RESPONSIVENESS
SANDER B; CARDELL S; MOLLER E
Journal article: IMMUNOLOGICAL REVIEWS. 1991;119:65-93
ASSESSMENT OF CYTOKINES BY IMMUNOFLUORESCENCE AND THE PARAFORMALDEHYDE-SAPONIN PROCEDURE
SANDER B; ANDERSSON J; ANDERSSON U
Journal article: EOS RIVISTA DI IMMUNOLOGIA ED IMMUNOFARMACOLOGIA. 1990;10(4):115-116
DETECTION OF INDIVIDUAL INTERLEUKIN-PRODUCING CELLS BY FLOW-CYTOMETRY
ANDERSSON U; SANDER B; ANDERSSON J
Journal article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 1989;30(3):315-320
DETECTION OF INDIVIDUAL INTERLEUKIN 4-PRODUCING AND GAMMA-INTERFERON-PRODUCING MURINE SPLEEN-CELLS AFTER ACTIVATION WITH T-CELL MITOGENS
SANDER B; CARDELL S; HEREMANS H; ANDERSSON U; MOLLER G
Journal article: IMMUNOLOGY LETTERS. 1989;20(2):115-120
DETECTION OF INDIVIDUAL INTERLEUKIN 2-PRODUCING CELLS AFTER ANTI-CD3 ANTIBODY ACTIVATION
ANDERSSON U; SANDER B
Journal article: EUROPEAN JOURNAL OF IMMUNOLOGY. 1988;18(12):2081-2084
CONCOMITANT PRODUCTION OF DIFFERENT LYMPHOKINES IN ACTIVATED T-CELLS
ANDERSSON U; SANDER B; ANDERSSON J; MOLLER G
Journal article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 1986;23(4):435-440
INHIBITION OF INVITRO ALLOREACTIVITY BY CYCLOSPORINE-A - EVIDENCE FOR AN INTERINDIVIDUAL VARIATION IN SENSITIVITY
SANDER B; BRIGATI C; MOLLER E
Journal article: IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY. 1985;7(3):285-302
CPH - 86, A HIGHLY PURIFIED PODOPHYLLOTOXIN, EFFICIENTLY SUPPRESSES INVIVO AND INVITRO IMMUNE-RESPONSES
BRIGATI C; SANDER B
Show more

All other publications

Letter: ANNALS OF INTERNAL MEDICINE. 2025;178(2):300-304
Germline UBA1 Variant With Somatic Amplification in a Woman With Inflammatory Diseases and Myelodysplastic Syndrome
Creignou M; Sirenko M; Moura PL; Mortera-Blanco T; Dimitriou M; Sander B; Domenico D; Ossa JEA; Tesi B; Beck DB; Woll P; Jacobsen S-EW; Papaemmanuil E; Bernard E; Hellstrom-Lindberg E
Letter: ACTA ONCOLOGICA. 2023;62(6):560-564
The BioLymph study - implementing precision medicine approaches in lymphoma diagnostics, treatment and follow-up: feasibility and first results
Smedby KE; Waesterlid T; Tham E; Haider Z; Joelsson J; Thorvaldsdottir B; Krstic A; Wahlin BE; Foroughi-Asl H; Karlsson C; Eloranta S; Saft L; Palma M; Kwiecinska A; Hansson L; Osterborg A; Wirta V; Rassidakis G; Sander B; Sonnevi K; Rosenquist R
Letter: HEMASPHERE. 2023;7(4):e863
Genetic and Microenvironment Features Do Not Distinguish Follicular Lymphoma Patients Requiring Immediate or Deferred Treatment
Stevens WBC; Los-de Vries GT; Langois-Jacques C; Clear AJ; Stathi P; Sander B; Rosenwald A; Calaminici M; Hoster E; Hiddemann W; Gaulard P; Salles G; Klapper W; Xerri L; Burton C; Tooze RM; Smith AG; Buske C; Scott DW; Natkunam Y; Advani R; Sehn LH; Raemaekers J; Gribben J; Lockmer S; Kimby E; Kersten MJ; Maucort-Boulch D; Ylstra B; van Dijk E; de Jong D
Corrigendum: VIRCHOWS ARCHIV. 2023;482(1):147-148
Chronic lymphocytic leukaemia/small lymphocytic lymphoma and mantle cell lymphoma: from early lesions to transformation (vol 482, pg 131, 2023)
Sander B; Campo E; Hsi ED
Review: VIRCHOWS ARCHIV. 2023;482(1):131-145
Chronic lymphocytic leukaemia/small lymphocytic lymphoma and mantle cell lymphoma: from early lesions to transformation
Sander B; Campo E; Hsi ED
Conference publication: BLOOD. 2022;140:1479-1480
Long-Term Follow-up of Clinical Outcome Determinants and Correlative Biological Features from the Nordic NLG-T-01 Trial
Relander T; Pedersen MB; Ellin F; Lauritzsen GF; Jantunen E; Hagberg H; Holte H; Osterborg A; Brown PDN; Kuittinen O; Erlanson M; Ostenstad B; Fagerli U-M; Delabie J; Sundstrom C; Sander B; Hamilton-Dutoit S; Ehinger M; Liestol K; Toldbod H; Feldman AL; D'Amore FA
Letter: BLOOD ADVANCES. 2022;6(16):4705-4709
The extent of residual WT HSPCs is associated with the degree of anemia in patients with SF3B1-mutated MDS-RS
Hofman IJF; Mortera-Blanco T; Moura PL; Vestlund J; Larsson SV; Elvarsdottir EM; Walldin G; Tobiasson M; Sander B; Dimitriou M; Jacobsen S-EW; Woll PS; Jadersten M; Hellstrom-Lindberg E
Letter: BLOOD CANCER JOURNAL. 2021;11(5):100
Real-world data on treatment and outcomes of patients with primary mediastinal large B-cell lymphoma: a Swedish lymphoma register study
Wasterlid T; Hasselblom S; Joelsson J; Weibull CE; Rassidakis G; Sander B; Smedby KE
Preprint: SSRN ELECTRONIC JOURNAL. 2021
RNA-Editing-Initiated MAVS Signaling is a Key Epitranscriptomic Alteration in Human B Cell Lymphoma
Pecori R; Ren W; Wang X; Berglund M; Li W; Tasakis RN; Di Giorgio S; Ye X; Arnold A; Wüst S; Selvasaravanan K-D; Fuell Y; Stafforst T; Amini R-M; Enblad G; Sander B; Wahlin BE; Zhang H; Binder M; Papavasiliou N; Pan-Hammarström Q
Editorial comment: BLOOD. 2020;136(12):1378-1379
Under the cover of mantle cell lymphoma
Sander B
Preprint: BIORXIV. 2020
Differential B-cell receptor signaling requirement for adhesion of mantle cell lymphoma cells to stromal cells
Sadeghi L; Arvidsson G; Merrien M; Wasik AM; Görgens A; Smith CIE; Sander B; Wright AP
Conference publication: BRITISH JOURNAL OF HAEMATOLOGY. 2020;189:102-103
Structural and functional variability of the tumour B-cell receptor indicates a role for environmental influences on the behaviour of mantle cell lymphoma
Dutton D; Chiodin G; Drennan S; Pitsillidou C; Henderson I; Tracy I; Wasik A; Gaidano G; Moia R; Johnson P; Stevenson F; Packham G; Sander B; Forconi F
Conference publication: BLOOD. 2019;134:5487
A Clinical Trial of Cannabis As Targeted Therapy for Indolent Leukemic Lymphoma
Melen CM; Merrien M; Wasik A; Sonnevi K; Junlen H-R; Christersson B; Sander B; Wahlin BE
Meeting abstract: BLOOD. 2019;134:5312
ROR1 Small Molecule Inhibitor (KAN0441571C) Induced Significant Apoptosis of Mantle Cell Lymphoma (MCL) Cells
Mellstedt H; Ghaderi A; Aschan J; Mozaffari F; Moshfegh A; Sander B; Schultz J; Norin M; Olin T; Drakos E; Rassidakis GZ; Osterborg A; Hojjat-Farsangi M
Meeting abstract: BLOOD. 2019;134:1618
Encouraging Outcomes with Intensive Chemotherapy for Patients with Primary Mediastinal B-Cell Lymphoma - a Swedish Lymphoma Register Study
Wasterlid T; Rassidakis GZ; Sander B; Smedby KE
Letter: LEUKEMIA & LYMPHOMA. 2019;60(13):3316-3319
Angioimmunoblastic T-cell lymphoma and myelodysplastic syndrome with mutations in TET2, DNMT3 and CUX1 - azacitidine induces only lymphoma remission
Tobiasson M; Pandzic T; Cavelier L; Sander B; Wahlin BE
Letter: HAEMATOLOGICA. 2018;103(12):e594-e597
Impact of Sox11 over-expression in Ba/F3 cells
Lord M; Arvidsson G; Wasik AM; Christensson B; Wright AP; Grandien A; Sander B
Conference publication: BLOOD. 2018;132:4121
Cannabinoid Receptors and CXCR4 Cross-Talk in Lymphoma Cells
Merrien M; Wasik AM; Melen C; Sonnevi K; Christensson B; Wahlin BE; Sander B
Meeting abstract: BLOOD. 2018;132:4130
The Novel Tumor Suppressor SAMHD1 Is Differentially Expressed and Partly Regulated By MYC in Peripheral T-Cell Lymphomas (PTCL)
Da Silva PFN; Tsesmetzis N; Xagoraris I; Wasik AM; Kokaraki G; Tzoras E; Osterborg A; Sander B; Herold N; Rassidakis G
Letter: AMERICAN JOURNAL OF HEMATOLOGY. 2018;93(8):E213-E215
Congenital dyserythropoietic anemia type 1: A case with novel compound heterozygous mutations in the C15orf41 gene
Palmblad J; Sander B; Bain B; Klimkowska M; Bjoerck E
Conference publication: TRANSPLANTATION AND CELLULAR THERAPY. 2018;24(3):S299
Strong Expression of P53 Protein in Bone Marrow after Hematopoietic Stem Cell Transplantation Indicates Risk of Relapse in Pediatric Acute Lymphoblastic Leukemia Patients
Gustafsson B; Mattsson K; Honkaniemi E; Sander B; Barbany G
Meeting abstract: BLOOD. 2018;132
SAMHD1 Is Variably Expressed in Mantle Cell Lymphoma and Correlated to SOX11 but Not to Survival
Wasik AM; Marin E; Merrien M; Rodrigues JDM; Lord M; Xagoraris I; Christensson B; Rassidakis G; Jerkeman M; Ek S; Sander B
Published conference paper: JOURNAL OF INTERNAL MEDICINE. 2017;282(5):395-414
Early stages in the ontogeny of small B-cell lymphomas: genetics and microenvironment
Ghia P; Nadel B; Sander B; Stamatopoulos K; Stevenson FK
Conference publication: BLOOD. 2016;128(22):4137
The G-Protein Coupled Receptors and G-Proteins Alpha Expression in Mantle Cell Lymphoma
Wasik AM; Mundt F; Christensson B; Sander B
Letter: LEUKEMIA & LYMPHOMA. 2016;57(11):2672-2676
The t(11;14)(q13;q32)/CCND1-IGH translocation is a recurrent secondary genetic aberration in relapsed chronic lymphocytic leukemia
Schliemann I; Oschlies I; Nagel I; Penas EMM; Siebert R; Sander B
Letter: LEUKEMIA. 2016;30(9):1953-1956
Detection of circulating mast cells in advanced systemic mastocytosis
Dahlin JS; Ungerstedt JS; Grootens J; Sander B; Guelen T; Haegglund H; Nilsson G
Review: VIRCHOWS ARCHIV. 2016;468(3):245-257
Mantle cell lymphoma-a spectrum from indolent to aggressive disease
Sander B; Quintanilla-Martinez L; Ott G; Xerri L; Kuzu I; Chan JKC; Swerdlow SH; Campo E
Review: VIRCHOWS ARCHIV. 2016;468(3):259-275
The many faces of small B cell lymphomas with plasmacytic differentiation and the contribution of MYD88 testing
Swerdlow SH; Kuzu I; Dogan A; Dirnhofer S; Chan JKC; Sander B; Ott G; Xerri L; Quintanilla-Martinez L; Campo E
Review: VIRCHOWS ARCHIV. 2016;468(2):127-139
The heterogeneity of follicular lymphomas: from early development to transformation
Xerri L; Dirnhofer S; Quintanilla-Martinez L; Sander B; Chan JKC; Campo E; Swerdlow SH; Ott G
Review: VIRCHOWS ARCHIV. 2016;468(2):141-157
Indolent lymphomas in the pediatric population: follicular lymphoma, IRF4/MUM1+lymphoma, nodal marginal zone lymphoma and chronic lymphocytic leukemia
Quintanilla-Martinez L; Sander B; Chan JKC; Xerri L; Ott G; Campo E; Swerdlow SH
Conference publication: HAEMATOLOGICA. 2016;101:69
A CULTURE MODEL MIMICKING THE BM-NICHE ALLOWS FOR STUDYING THE DYSREGULATED ERYTHROPOIESIS OF SF3B1 MUTATED MYELODYSPLASTIC SYNDROME WITH RINGED SIDEROBLASTS
Elvarsdottir EM; Mortera-Blanco T; Dimitriou M; Conte S; Sander B; Jansson M; Douagi I; Jacobsen SE; Hellstrom-Lindberg E
Conference publication: BLOOD. 2015;126(23):1535
Sequential Immune Cell Modulation in Nordic Follicular Lymphoma Patients in the SAKK 35/10 Randomized Trial with Rituximab and Lenalidomide
Lockmer S; Wahlin BE; Ostenstad B; Jeppson-Ahlberg A; Sander B; Kimby E
Conference publication: BLOOD. 2015;126(23):4996
Low Expression of p53 Protein in Bone Marrow after Hematopoietic Stem Cell Transplantation Indicates Risk of Relapse in Pediatric Patients with Acute Lymphoblastic Leukemia
Mattsson K; Honkaniemi E; Sander B; Custafsson BS
Letter: HAEMATOLOGICA. 2015;100(9):e369-e372
The utility of mRNA analysis in defining SOX11 expression levels in mantle cell lymphoma and reactive lymph nodes
Lord M; Wasik AM; Christensson B; Sander B
Editorial comment: CELL CYCLE. 2015;14(3):291-292
Cannabinoid receptors in mantle cell lymphoma
Wasik AM; Sander B
Conference publication: BLOOD. 2014;124(21):3005
How Many Ontogenetic Roads to Mantle-Cell Lymphoma? Immunogenetic and Immunohistochemical Evidence
Pouliou E; Xochelli A; Stalika E; Sutton L-A; Navarro A; Agathangelidis A; Dimosthenous K; Kanellis G; Anagnostopoulos A; Patsouris E; Korkolopoulou P; Sundstrom C; Ghia P; Ponzoni M; Sander B; Campo E; Rosenquist R; Hadzidimitriou A; Stamatopoulos K; Papadaki T
Conference publication: BLOOD. 2014;124(21):297
Recurrent Mutations within the Nfkbie gene: A Novel Mechanism for NF-κB Deregulation in Aggressive Chronic Lymphocytic Leukemia
Mansouri L; Sutton L-A; Ljungstrom V; Bondza S; Arngarden L; Bhoi S; Larsson J; Cortese D; Kalushkova A; Gunnarsson R; Young E; Falk-Sorqvist E; Plevova K; Muggen A; Yan X-J; Sander B; Enblad G; Smedby KE; Juliusson G; Belessi C; Chiorazzi N; Strefford JC; Langerak AW; Pospisilova S; Davi F; Hellstrom M; Wiklund HJ; Ghia P; Soderberg O; Stamatopoulos K; Nilsson M; Rosenquist R
Editorial comment: LANCET. 2014;383(9928):1608
Flushing, fatigue, and recurrent anaphylaxis: a delayed diagnosis of mastocytosis
Gulen T; Hagglund H; Dahlen S-E; Sander B; Dahlen B; Nilsson G
Conference publication: HAEMATOLOGICA. 2014;99:688
PERTURBATIONS OF THE ENDOCANNABINOID SYSTEM IN MANTLE CELL LYMPHOMA; CORRELATIONS TO CLINICAL AND PATHOLOGICAL FEATURES
Wasik A; Nygren L; Almestrand S; Zong F; Flygare J; Wennerholm SB; Saft L; Andersson P; Kimby E; Christensson B; Sander B
Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2014;80(3):237-238
Perturbations of the Endocannabinoid System in Mantle Cell Lymphoma; Correlations to Clinical and Pathological Features
Wasik AM; Nygren L; Almestrand S; Zong F; Flygare J; Baumgartner-Wennerholm S; Saft L; Andersson P; Kimby E; Christensson B; Sander B
Conference publication: HAEMATOLOGICA. 2014;99:139
DETECTION OF SOX11 PROTEIN BY FLOW CYTOMETRY
Lord M; Wasik A; Priebe V; Jeppsson-Ahlberg A; Christensson B; Sander B
Meeting abstract: BLOOD. 2013;122(21):1787
T-Cell Frequencies In MCL Are Of Prognostic Importance In a Large Population-Based Cohort
Nygren L; Baumgartner-Wennerholm S; Asa J-A; Klimkowska M; Wasik AM; Andersson P; Buhrkuhl D; Christensson B; Wahlin BE; Kimby E; Sander B
Meeting abstract: BLOOD. 2013;122(21):2408
Erythropoiesis In SF3B1 Mutated RARS Is Disrupted During Terminal Erythroid Maturation
Conte S; Vesterlund L; Katayama S; Karimi M; Papaemmanuil E; Jansson M; Mortera-Blanco T; Dimitriou M; Sander B; Skoog T; Campbell PJ; Kere J; Unneberg P; Hellstroem-Lindberg E
Meeting abstract: LEUKEMIA RESEARCH. 2013;37:S24-S25
Aberrant splicing during erythroid differentiation in SF3B1 mutated sideroblastic anemia
Conte S; Vesterlund L; Katayama S; Karimi M; Unneberg P; Papaemmanuil E; Jansson M; Mortera-Blanco T; Dimitriou M; Sander B; Skoog T; Campbell P; Kere J; Hellstrom-Lindberg E
Conference publication: HAEMATOLOGICA. 2013;98:124
LYMPHOMAS AS ESTROGEN RELATED DISEASES - POSSIBLE TARGET FOR ESTROGEN RECEPTOR BETA AGONIST TREATMENT.
Yakimchuk K; Hasni MS; Guan J; Nilsson S; Jondal M; Sander B; Okret S
Conference publication: HAEMATOLOGICA. 2013;98:460
A KEY ROLE FOR EZH2 IN EPIGENETIC SILENCING OF HOX GENES IN MANTLE CELL LYMPHOMA
Kanduri M; Sander B; Stamatopoulos K; Kanduri C; Rosenquist R
Conference publication: HAEMATOLOGICA. 2013;98:73-74
ABERRANT SPLICING DURING ERYTHROID DIFFERENTIATION IN SF3B1 MUTATED SIDEROBLASTIC
Conte S; Vesterlund L; Katayama S; Karimi M; Unneberg P; Papaemmanuil E; Jansson M; Mortera-Blanco T; Dimitriou M; Sander B; Skoog T; Campbells P; Kere J; Hellstrom-Lindberg E
Conference publication: HAEMATOLOGICA. 2013;98:351-352
ANALYSIS OF SOX11, SOX4 AND SOX12 IN MANTLE CELL LYMPHOMA
Sander B; Wasik A; Lord M; Wang X; Zong F; Andersson P; Kimby E; Christensson B; Karimi M
Conference publication: BLOOD. 2012;120(21):895
SOX11 Directly Represses Wnt/β-Catenin Signaling and Identifies a Subgroup of Mantle Cell Lymphoma Patients with Improved Survival with Intensive Treatment
Kuo P-Y; Leshchenko VV; Fazzari MJ; Gellen TA; Iqbal J; Baumgartner-Wennerholm S; Nygren L; Suh KS; Goy A; Yang DT; Chan W-C; Kahl BS; Verma A; Gascoyne RD; Kimby E; Sander B; Ye BH; Melnick A; Parekh S
Conference publication: ALLERGY. 2012;67:564
Prevalence of anaphylaxis is increased in patients with systemic mastocytosis
Gulen T; Dahlen B; Sander B; Hagglund H; Nilsson G
Letter: LEUKEMIA. 2011;25(12):1904-1908
Impact of TP53 mutation and 17p deletion in mantle cell lymphoma
Halldorsdottir AM; Lundin A; Murray F; Mansouri L; Knuutila S; Sundstrom C; Laurell A; Ehrencrona H; Sander B; Rosenquist R
Editorial comment: SEMINARS IN CANCER BIOLOGY. 2011;21(5):291-292
Mantle cell lymphoma
Sander B
Review: SEMINARS IN CANCER BIOLOGY. 2011;21(5):313-321
The role of cannabinoid receptors and the endocannabinoid system in mantle cell lymphoma and other non-Hodgkin lymphomas
Wasik AM; Christensson B; Sander B
Conference publication: EUROPEAN JOURNAL OF CANCER. 2011;47:S649
Cytogenetic Abnormalities in the Spleen Detected by FISH in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Norin S; Wallblom A; Sander B; Kimby E
Conference publication: BLOOD. 2011;118(21):1560
SOX11 Expression Versus Indolent Clinical Course in Mantle Cell Lymphomas in a Population-Based Cohort From the Stockholm Region-SOX11 Negative Tumors Are Mostly p53 Positive, Contributing to Shorter Overall Survival
Sander B; Klimkowska M; Nygren L; Baumgartner S; Christensson B; Kimby E
Conference publication: BLOOD. 2011;118(21):692
Prognostic Impact of Clinical and Tumor Associated Variables in a Population-Based Cohort of Mantle Cell Lymphomas in the Stockholm Region Between 1998-2010
Wennerholm SB; Klimkowska M; Nygren L; Kimby E; Sander B
Conference publication: ANNALS OF ONCOLOGY. 2011;22:220
PROGNOSTIC IMPACT OF CLINICAL AND TUMOR ASSOCIATED VARIABLES IN A POPULATION-BASED COHORT OF MANTLE CELL LYMPHOMAS IN THE STOCKHOLM REGION BETWEEN 1998-2010
Baumgartner S; Klimkowska M; Nygren L; Kimby E; Sander B
Conference publication: BLOOD. 2011;118(21):713
Increasing Grades of Follicular Lymphoma Correlate with Better Prognosis in Patients Treated with Rituximab
Wahlin BE; Sundstrom C; Holte H; Sander B; Ostenstad B; Brown PDN; Smeland EB; Delabie J; Christensson B; Kimby E
Conference publication: ANNALS OF ONCOLOGY. 2011;22:108
THE RELIABILITY OF IMMUNOHISTOCHEMICAL ANALYSIS OF TUMOR MICROENVIRONMENT IN FOLLICULAR LYMPHOMA; A VALIDATION STUDY FROM THE LUNENBURG LYMPHOMA BIOMARKER CONSORTIUM (LLBC)
De Jong D; Wahlin B; Sander B; Xie W; Salles G; Weller E
Conference publication: ALLERGY. 2011;66:152
Systemic mastocytosis - the disease with the many faces. The Swedish experience
Gulen T; Nilsson G; Dahlen S; Dahlen B; Saaf M; Emtestam L; Bendix M; Billgert L; Sander B; Hagglund H
Conference publication: BLOOD. 2010;116(21):239
Genome-Wide Array-Based Methylation Profiling Reveals Preferential Methylation of Homeobox Transcription Factor Genes in Mantle Cell Lymphoma and Pro-Apoptotic Genes In Chronic Lymphocytic Leukemia
Halldorsdottir AM; Kanduri M; Marincevic M; Goransson H; Isaksson A; Mansouri M; Stamatopoulos K; Sander B; Ehrencrona H; Rosequist R
Conference publication: HAEMATOLOGICA. 2010;95:171
CHARACTERIZATION OF COPY-NUMBER ABERRATIONS IN MANTLE CELL LYMPHOMA WITH HIGH-RESOLUTION GENOMIC ARRAYS: CORRELATION WITH GENOMIC COMPLEXITY AND THE PROLIFERATION GENE EXPRESSION SIGNATURE
Halldorsdottir M; Sander B; Goransson H; Isaksson A; Mansouri M; Rosenquist R; Ehrencrona H
Conference publication: BLOOD. 2009;114(22):1520
Several Immune Cell Subsets Are Associated with Outcome in the Microenvironment of Follicular Lymphoma
Wahlin BE; Aggarwal M; Montes-Moreno S; Francisco Gonzalez L; Roncador G; Sanchez-Verde L; Christensson B; Sander B; Kimby E
Letter: BRITISH JOURNAL OF HAEMATOLOGY. 2008;143(5):751-753
Transmission of chronic lymphocytic leukaemia from a blood stem cell sibling donor to the recipient
Nahi H; Jansson M; Sander B; Ljungman P; Hagglund H
Review: LAKARTIDNINGEN. 2008;105(46):3341-3347
[Mastocytosis--a disease with many faces. Investigation and treatment should be performed in consultation with Karolinska University Hospital].
Hägglund H; Gülen T; Sääf M; Sander B; Nilsson G
Review: SEMINARS IN CANCER BIOLOGY. 2008;18(3):176-189
The endocannabinoid system in cancer - Potential therapeutic target?
Flygare J; Sander B
Letter: AMERICAN JOURNAL OF CLINICAL PATHOLOGY. 2008;130(6):1010-1011
A Subset of CD5-Diffuse Large B-Cell Lymphomas Expresses Nuclear Cyclin D1 With Aberrations at the CCND1 Locus Reply
Ehinger M; Sander B
Conference publication: BONE MARROW TRANSPLANTATION. 2008;41:S196
Transmission of CLL from a blood stem cell sibling donor to the recipient
Nahi H; Jansson M; Sander B; Ljungman P; Hagglund H
Letter: PEDIATRIC BLOOD & CANCER. 2007;49(7):1054-1055
Myelodysplastic features and symptoms mimicking cystic fibrosis in a child with an intracellular vitamin B 12 deficiency
Gustafsson B; Karpati F; Nordenstrom A; Soederhaell S; Sander B; Nordvall M; von Doebeln U
Conference publication: BLOOD. 2007;110(11):768A-769A
Grading follicular lymphoma: No difference between 1, 2 and 3a, but 3b is something else
Wahlin BE; Sander B; Christerisson B; Kimby E
Letter: LEUKEMIA. 2006;20(12):2204-2007
Alemtuzumab as first-line therapy for B-cell chronic lymphocytic leukemia:: long-term follow-up of clinical effects, infectious complications and risk of Richter transformation
Karlsson C; Norin S; Kimby E; Sander B; MacDonald AP; Nilsson B; Johansson E; Mellstedt H; Lundin J; Osterborg A
Meeting abstract: BLOOD. 2006;108(11):579A
A small subset of CD5-negative diffuse large B-cell lymphomas express nuclear cyclin D1 with evidence of amplified cyclin D1 signals or the t(11;14) translocation.
Ehinger M; Linderoth J; Christensson B; Sander B; Stahl E
Conference publication: BLOOD. 2006;108(11):256A-257A
Lenalidomide up-regulates SPARC and inhibits in vitro growth of the malignant clone in myelodysplastic syndrome patients with 5q deletion.
Pellagatti A; Jadersten M; Forsblom A-M; Cattan H; Christensson B; Emanuelsson EK; Merup M; Nilsson L; Samuelsson J; Sander B; Wainscoat JS; Boultwood J; Hellstrom-Lindberg E
Letter: LEUKEMIA. 2005;19(2):310-312
Mutations in the BRAF and N-ras genes in childhood acute lymphoblastic leukaemia
Gustafsson B; Angelini S; Sander B; Christensson B; Hemminki K; Kumar R
Conference publication: CHROMOSOME RESEARCH. 2005;13:180
Investigating cyclin B1 positive subpopulation in Mantle cell lymphoma using FICTION on paraffin embedded tissue
Emanuelsson EK; Jansson M; Fahlstrom G; Hassan M; Sander B
Conference publication: ANNALS OF ONCOLOGY. 2005;16:95
Mast cells and eosinophils as prognostic factors in mantle cell lymphoma
Berlin J; Walsh S; Simonsson M; Qvarnström F; Sander B; Enblad G; Rosenquist R; Molin D
Conference publication: ANNALS OF ONCOLOGY. 2005;16:168
Mantle cell lymphoma: Chromosomal aberrations, proliferaton and cyclin D1 transcripts in relation to clincial outcome
Kimby E; Wallblom A; Sander B
Meeting abstract: BLOOD. 2004;104(11):889A
T-cells present in tumour tissue may affect the outcome of follicular lymphoma
Wahlin BE; Kimby E; Sander B; Christensson B
Conference publication: BLOOD. 2002;100(11):285B-286B
Mantle cell lymphoma - blastoid variants associated to a particular CCND1 (Cyclin D1) probe set expression pattern.
Sander B; Islam T; Nygren L; Kimby EK; Lennartsson P; Smith CIE; Christensson B
Conference publication: BLOOD. 2002;100(11):285B
Lymphomas after 500 liver transplantations -: A single centre experience.
Norin S; Kimby EK; Ericzon BG; Söderdahl G; Christensson B; Sander B; Hágglund H
Conference publication: BLOOD. 2002;100(11):567A
Mantle cell lymphoma - New insights based on immunoglobudin variable heavy chain gene analysis.
Walsh S; Thorselius M; Johnson A; Soderberg O; Jerkeman M; Bjorck E; Eriksson I; Thunberg U; Ehinger M; Enblad G; Sander B; Porwit A; Dictor M; Olofsson T; Sundstrom C; Roos G; Rosenquist R
Letter: ARCHIVES OF DERMATOLOGY. 1997;133(11):1459-1460
Malignant melanoma vs benign tumors in the young.
Rosdahl I; Karlsson P; Boeryd B; Sander B; Westermark P
Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 1988;28(2):263
DETECTION OF CYTOKINE PRODUCTION AT THE SINGLE CELL LEVEL
SANDER B; CARDELL S; ANDERSSON U
Show more

Grants

Molecular pathogenesis of B-cell lymphomas with focus on novel therapy targets and biological factors for relapsing disease.
Swedish Research Council
1 January 2020 - 31 December 2022
Studies of disease mechanisms in lymphoma with focus on cannabinoid receptors, signals that protect the lymphoma cells in the tissue and the significance of the transcription factor SOX11.
Swedish Cancer Society
1 January 2018
Lymphoma Disease Mechanisms - The Importance of Cannabinoid Receptors and SOXC Transcription Factors.
Swedish Cancer Society
1 January 2017
Lymphoma Disease Mechanisms - The Importance of Cannabinoid Receptors and SOXC Transcription Factors.
Swedish Cancer Society
1 January 2016
Lymphoma Disease Mechanisms - The Importance of Cannabinoid Receptors and SOXC Transcription Factors.
Swedish Cancer Society
1 January 2015
Lymphoma Disease Mechanisms - Molecular and Functional Studies.
Swedish Cancer Society
1 January 2014
The endocannabinoid system in normal B cells and in malignant lymphoma - function, regulation and therapeutic targeting.
Swedish Research Council
1 January 2011 - 31 December 2013

Employments

Professor Emeritus/Emerita, Department of Laboratory Medicine, Karolinska Institutet, 2024-2025
Professor/Senior Physician, Department of Laboratory Medicine, Karolinska Institutet, 2011-2024

Degrees and Education

Docent, Karolinska Institutet, 2002

News from KI

Events from KI